These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2859789)

  • 1. Rationale for beta-adrenergic blocking drugs in cardiomyopathy.
    Fowler MB; Bristow MR
    Am J Cardiol; 1985 Apr; 55(10):120D-124D. PubMed ID: 2859789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic function in heart muscle disease and heart failure.
    Bristow MR; Kantrowitz NE; Ginsburg R; Fowler MB
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():41-52. PubMed ID: 2863387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy.
    Gilbert EM; Olsen SL; Renlund DG; Bristow MR
    Am J Cardiol; 1993 Mar; 71(9):23C-29C. PubMed ID: 8096672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the beta-adrenergic signaling pathway in human heart failure.
    Hamdani N; Linke WA
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2522-31. PubMed ID: 22280427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?
    Alderman J; Grossman W
    Circulation; 1985 May; 71(5):854-7. PubMed ID: 2859129
    [No Abstract]   [Full Text] [Related]  

  • 6. The sympathetic nervous system in chronic heart failure.
    Joseph J; Gilbert EM
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy.
    Feldman AM; Bristow MR
    Cardiology; 1990; 77 Suppl 1():1-32. PubMed ID: 1970755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart.
    Vatner DE; Asai K; Iwase M; Ishikawa Y; Shannon RP; Homcy CJ; Vatner SF
    Am J Cardiol; 1999 Jun; 83(12A):80H-85H. PubMed ID: 10750593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.
    Gilbert EM; O'Connell JB; Bristow MR
    Heart Vessels Suppl; 1991; 6():29-39. PubMed ID: 1687924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
    Nikolaidis LA; Trumble D; Hentosz T; Doverspike A; Huerbin R; Mathier MA; Shen YT; Shannon RP
    Eur J Heart Fail; 2004 Jun; 6(4):409-19. PubMed ID: 15182765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradox of beta-adrenergic blockade for the management of congestive heart failure.
    Eichhorn EJ
    Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenergic betablockers and heart failure].
    Lechat P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):611-5. PubMed ID: 7487311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.
    Perez DM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)].
    Sigmund M; Reineke T
    Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-adrenergic receptors.
    Wallukat G
    Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.